Exelixis (EXEL) Net Income (QoQ) (2010 - 2026)
Exelixis (EXEL) Net Income (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,140.12 Bn | 66,139.83 Bn | - |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - |
| 3 | Akari Therapeutics | 1,022.34 Bn | 1,022.34 Bn | - |
| 4 | BeOne Medicines | 472.04 Bn | 467.25 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.28 Bn | 115.03 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.07 Bn | 61.31 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.66 Bn | 62.66 Bn | - |
| 8 | Argenx Se | 56.16 Bn | 50.98 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.56 Bn | 34.55 Bn | 959.66 Mn |
| 10 | Exelixis | 14.47 Bn | 13.69 Bn | 590.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | -13.93% |
| Jan 2, 2026 | 26.32% |
| Oct 3, 2025 | 4.72% |
| Jul 4, 2025 | 15.81% |
| Apr 4, 2025 | 14.12% |
| Jan 3, 2025 | 18.55% |
| Sep 27, 2024 | -47.83% |
| Jun 28, 2024 | 505.93% |
| Mar 29, 2024 | -56.36% |
| Dec 29, 2023 | 8,114.99% |
| Sep 29, 2023 | -98.72% |
| Jun 30, 2023 | 102.80% |
| Mar 31, 2023 | 232.66% |
| Dec 30, 2022 | -141.21% |
| Sep 30, 2022 | 3.59% |
| Jul 1, 2022 | 3.06% |
| Apr 1, 2022 | -27.94% |
| Dec 31, 2021 | 149.10% |
| Oct 1, 2021 | -60.24% |
| Jul 2, 2021 | 5,902.00% |